0,783  0,004  5 Hydroxytryptamine release stimulant
0,583  0,009  Hypoglycemic
0,562  0,018  Sensitization
0,544  0,003  Neurotrophic factor enhancer
0,572  0,040  Caspase 9 stimulant
0,535  0,004  Antiparkinsonian, rigidity relieving
0,545  0,026  Cholesterol antagonist
0,532  0,016  Antiischemic
0,521  0,010  CYP3A4 inhibitor
0,500  0,015  Cardiodepressant
0,496  0,019  NOS2 expression inhibitor
0,480  0,009  Anesthetic general
0,502  0,045  Antineoplastic (lung cancer)
0,492  0,035  5 Hydroxytryptamine release inhibitor
0,466  0,020  Vasodilator, coronary
0,477  0,032  Respiratory analeptic
0,474  0,029  Antihypercholesterolemic
0,469  0,041  Histamine release inhibitor
0,446  0,028  Antihypertensive
0,445  0,030  Cardioprotectant
0,448  0,035  CYP2C19 substrate
0,423  0,013  Abortion inducer
0,404  0,007  Erectile dysfunction treatment
0,436  0,043  Ulceration
0,426  0,036  Caspase 3 stimulant
0,441  0,055  GST A substrate
0,441  0,055  Transcription factor NF kappa B inhibitor
0,423  0,039  CYP2D6 substrate
0,395  0,014  Hepatoprotectant
0,465  0,085  Apoptosis agonist
0,427  0,049  CYP2C19 inhibitor
0,387  0,010  Amylase inhibitor
0,393  0,017  Skin irritative effect
0,392  0,023  Angiogenesis stimulant
0,389  0,020  Eye irritation, high
0,379  0,013  Male reproductive disfunction treatment
0,381  0,017  Muscle relaxant
0,401  0,038  Apoptosis antagonist
0,397  0,035  Antioxidant
0,366  0,009  Antiparkinsonian, tremor relieving
0,398  0,044  Hepatic disorders treatment
0,366  0,014  Melanin inhibitor
0,411  0,060  Antileukemic
0,356  0,009  Amyloid beta precursor protein antagonist
0,350  0,005  CDC-like kinase 1 inhibitor
0,395  0,051  Bone diseases treatment
0,415  0,072  TNF expression inhibitor
0,372  0,031  Chemopreventive
0,403  0,062  CYP2C9 substrate
0,367  0,027  Antineoplastic (small cell lung cancer)
0,343  0,003  CDC-like kinase 3 inhibitor
0,345  0,007  Carcinogenic, group 1
0,389  0,059  Vasodilator, peripheral
0,351  0,020  Myocardial ischemia treatment
0,363  0,036  Antipyretic
0,371  0,045  Analeptic
0,388  0,066  CYP3A4 substrate
0,352  0,031  Psychostimulant
0,334  0,019  Antiseptic
0,327  0,015  Acaricide
0,328  0,017  Skeletal muscle relaxant
0,346  0,039  Antineoplastic (lymphoma)
0,301  0,003  Endothelin receptor antagonist
0,351  0,056  12-Lipoxygenase inhibitor
0,345  0,054  Spasmolytic
0,343  0,052  Antiosteoporotic
0,343  0,052  CYP2D6 inhibitor
0,330  0,040  Antiglaucomic
0,295  0,006  Alcohol dehydrogenase substrate
0,343  0,056  Antineoplastic (melanoma)
0,330  0,044  Free radical scavenger
0,289  0,003  DOPA decarboxylase inhibitor
0,335  0,055  CTGF expression inhibitor
0,335  0,058  Antineoplastic (brain cancer)
0,300  0,024  Thrombolytic
0,298  0,023  Diuretic
0,274  0,004  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,320  0,051  Antihypoxic
0,283  0,017  Cystic fibrosis treatment
0,284  0,018  CNS active muscle relaxant
0,333  0,070  ICAM1 expression inhibitor
0,320  0,060  CYP1A2 substrate
0,285  0,030  VCAM1 expression inhibitor
0,316  0,063  Lipoprotein disorders treatment
0,308  0,055  Chemoprotective
0,260  0,012  5 Hydroxytryptamine 3E antagonist
0,300  0,052  Proliferative diseases treatment
0,288  0,042  Antihypertriglyceridemic
0,296  0,053  Antineoplastic (renal cancer)
0,263  0,021  Genotoxic
0,287  0,047  Carcinogenic
0,334  0,100  Antipruritic, allergic
0,253  0,019  Antineoplastic (bone cancer)
0,236  0,003  Endothelin A receptor antagonist
0,262  0,031  CYP2B6 inhibitor
0,244  0,014  Phobic disorders treatment
0,241  0,013  Excitatory amino acid transporter EAAC1 inhibitor
0,335  0,108  15-Lipoxygenase inhibitor
0,235  0,010  Cyclooxygenase 3 inhibitor
0,227  0,003  Endothelin B receptor antagonist
0,279  0,056  Hypolipemic
0,323  0,099  CYP2C9 inhibitor
0,272  0,050  Tyrosine 3 hydroxylase inhibitor
0,229  0,008  Sphingosine 1-phosphate receptor 2 agonist
0,239  0,020  Antifungal enhancer
0,275  0,058  Cytostatic
0,246  0,030  Hair growth stimulant
0,315  0,106  Immunosuppressant
0,212  0,007  Sphingosine 1-phosphate receptor 5 antagonist
0,273  0,071  GST M1-1 substrate
0,261  0,060  DNA synthesis inhibitor
0,243  0,043  Pneumotoxic
0,217  0,018  Carcinogenic, group 2B
0,273  0,074  UGT2B4 substrate
0,208  0,010  Adenylate cyclase stimulant
0,238  0,040  Antipruritic, non-allergic
0,239  0,041  Insulin sensitizer
0,232  0,037  Tumour necrosis factor antagonist
0,309  0,115  Antineoplastic (breast cancer)
0,219  0,027  Uterine stimulant
0,260  0,068  Gastrin inhibitor
0,220  0,029  Alpha-N-acetylglucosaminidase inhibitor
0,224  0,033  Succinate dehydrogenase inhibitor
0,217  0,027  Renal failure treatment
0,262  0,078  Aldehyde oxidase inhibitor
0,255  0,071  Embryotoxic
0,196  0,014  Uric acid excretion stimulant
0,334  0,153  Antineoplastic (solid tumors)
0,205  0,025  Topoisomerase I inhibitor
0,210  0,031  Insulin secretagoues
0,281  0,102  Antithrombotic
0,209  0,033  Bone formation stimulant
0,212  0,039  Antineoplastic (squamous cell carcinoma)
0,259  0,087  Radioprotector
0,322  0,149  Alpha-glucosidase inhibitor
0,178  0,007  Phosphodiesterase V inhibitor
0,205  0,037  UGT2B9 substrate
0,251  0,082  UGT1A9 substrate
0,196  0,029  Raynaud's phenomenon treatment
0,224  0,059  Nitric oxide antagonist
0,198  0,034  Topoisomerase II inhibitor
0,170  0,007  Restless leg syndrome treatment
0,181  0,018  Vanilloid 1 agonist
0,241  0,079  Teratogen
0,198  0,038  UGT2B10 substrate
0,163  0,004  Endocannabinoid uptake inhibitor
0,167  0,010  Glutamate decarboxylase inhibitor
0,236  0,080  Antiprotozoal (Leishmania)
0,165  0,009  Phosphodiesterase 5A inhibitor
0,196  0,041  Thiol protease inhibitor
0,266  0,112  FMO1 substrate
0,171  0,018  Calcium antagonist
0,225  0,071  Peptidyltransferase inhibitor
0,199  0,047  Antiviral (Herpes)
0,241  0,089  Antiprotozoal (Trypanosoma)
0,169  0,017  Antiviral (Papilloma)
0,158  0,008  Phosphodiesterase 6D inhibitor
0,170  0,021  Sphingosine 1-phosphate receptor 2 antagonist
0,168  0,021  HDL-cholesterol increasing
0,170  0,023  Interleukin 8 antagonist
0,193  0,047  Antirickettsial
0,215  0,071  Clk dual-specificity kinase inhibitor
0,157  0,013  Keratolytic
0,162  0,018  Carcinogenic, group 2A
0,188  0,045  Arachidonic acid antagonist
0,169  0,029  Microtubule formation inhibitor
0,153  0,015  Inducible nitric-oxide synthase inhibitor
0,193  0,056  3C-like protease (Human coronavirus) inhibitor
0,300  0,163  Antidiabetic
0,300  0,163  Cyclophilin D inhibitor
0,271  0,134  Calpain 2 inhibitor
0,177  0,042  Cell wall synthesis inhibitor
0,139  0,005  Antiviral (Parainfluenza)
0,186  0,053  Aldehyde oxidase substrate
0,195  0,064  UGT2B7 substrate
0,159  0,029  Heat shock protein 70 antagonist
0,158  0,028  Mucolytic
0,185  0,055  Phospholipase C inhibitor
0,175  0,046  Tubulin antagonist
0,220  0,091  Cardiovascular analeptic
0,141  0,013  Phosphodiesterase XI inhibitor
0,141  0,013  Phosphodiesterase 11A inhibitor
0,138  0,010  GABA aminotransferase inhibitor
0,182  0,055  ATPase inhibitor
0,156  0,029  Papain-like protease (SARS coronavirus) inhibitor
0,160  0,034  Aminopeptidase B inhibitor
0,238  0,113  NOS3 expression inhibitor
0,171  0,046  SULT1A3 substrate
0,236  0,113  Hypoxia-inducible factor 1 alpha inhibitor
0,187  0,067  LDLR expression enhancer
0,179  0,059  Muscular dystrophy treatment
0,190  0,072  Mutagenic
0,210  0,093  Antihypotensive
0,170  0,053  Aldose reductase substrate
0,120  0,005  Alpha-mannosidase inhibitor
0,173  0,057  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,122  0,009  Estrogen-related receptor beta agonist
0,120  0,007  Antitreponemal
0,162  0,050  Carcinogenic, group 3
0,142  0,032  UGT2B1 substrate
0,126  0,016  Vanilloid agonist
0,129  0,020  Ornithine decarboxylase inhibitor
0,107  0,005  Mannosidase inhibitor
0,112  0,010  GABA B receptor agonist
0,185  0,083  UGT1A1 substrate
0,148  0,048  Ca2+-transporting ATPase inhibitor
0,180  0,081  Wound healing agent
0,195  0,096  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,106  0,008  Glutamate (mGluR7) antagonist
0,118  0,020  Aminopeptidase I inhibitor
0,218  0,119  Radiosensitizer
0,121  0,027  Antiviral (Rhinovirus)
0,122  0,029  ABCA1 expression enhancer
0,096  0,004  GABA uptake inhibitor
0,144  0,053  Antihyperlipoproteinemic
0,125  0,035  Nitric-oxide synthase inhibitor
0,116  0,026  Phosphofructokinase-1 inhibitor
0,175  0,085  Platelet adhesion inhibitor
0,106  0,017  Phosphodiesterase VI inhibitor
0,125  0,036  Antineoplastic alkaloid
0,134  0,045  Falcipain 3 inhibitor
0,118  0,030  Topoisomerase II alpha inhibitor
0,113  0,025  ATPase (Vacuolar H+) inhibitor
0,132  0,046  Antiviral (Influenza B)
0,124  0,038  Sphingomyelinase inhibitor
0,212  0,128  Lipoxygenase inhibitor
0,178  0,095  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,098  0,015  Alpha tubulin antagonist
0,158  0,078  Prostate disorders treatment
0,133  0,052  Sphingosine 1-phosphate receptor 4 antagonist
0,122  0,042  UDP-glucose 4-epimerase inhibitor
0,117  0,037  UGT2B11 substrate
0,151  0,073  Heat shock protein 90 antagonist
0,125  0,047  Expectorant
0,091  0,014  Heat shock protein 90 beta antagonist
0,157  0,080  Sigma receptor agonist
0,124  0,047  GABA C receptor agonist
0,112  0,037  Triose-phosphate isomerase inhibitor
0,148  0,074  Antianorexic
0,092  0,019  Protease 3C (Human rhinovirus) inhibitor
0,192  0,121  Calpain inhibitor
0,186  0,115  Nitric-oxide synthase stimulant
0,130  0,060  Adenylate cyclase inhibitor
0,188  0,119  RNA-directed DNA polymerase inhibitor
0,109  0,039  Paget's disease treatment
0,124  0,055  Antifungal (Pneumocystis)
0,107  0,038  Antidote, mercury
0,151  0,082  UGT1A3 substrate
0,180  0,111  Cyclic AMP phosphodiesterase inhibitor
0,128  0,060  Cell adhesion inhibitor
0,103  0,036  Transcription factor NF kappa B stimulant
0,100  0,034  Macrophage migration inhibitory factor inhibitor
0,114  0,048  GST T1-1 substrate
0,146  0,082  Urolithiasis treatment
0,205  0,142  5 Hydroxytryptamine uptake stimulant
0,075  0,013  Ryanodine receptor antagonist
0,072  0,010  Factor III inhibitor
0,072  0,011  Adenylate cyclase 1 inhibitor
0,138  0,077  Pregnane X receptor agonist
0,138  0,077  Protein kinase stimulant
0,177  0,117  UGT1A6 substrate
0,110  0,051  Antihypermotility
0,189  0,130  Cardiotonic
0,149  0,090  Interleukin 6 antagonist
0,161  0,103  Non-steroidal antiinflammatory agent
0,128  0,070  Toll-Like receptor 2 antagonist
0,075  0,017  Leukotriene B4 antagonist
0,111  0,055  Protease inhibitor
0,084  0,028  Anticholelithogenic
0,121  0,065  Antineoplastic antimetabolite
0,124  0,068  Coagulant
0,121  0,066  Acetylcholine muscarinic antagonist
0,205  0,150  Insulysin inhibitor
0,160  0,107  Pyruvate kinase inhibitor
0,138  0,084  Antidote
0,087  0,034  Antidote, organophosphates
0,155  0,102  Cytotoxic
0,066  0,014  Glucose-6-phosphate isomerase inhibitor
0,177  0,125  Vasodilator
0,060  0,008  Vesicle monoamine transporter inhibitor
0,078  0,028  Exportin-1 inhibitor
0,127  0,076  Anesthetic
0,098  0,048  Actinic keratosis treatment
0,077  0,028  Glutamate (mGluR6) antagonist
0,095  0,046  Antispirochetal
0,054  0,005  Sodium/glucose cotransporter 2 inhibitor
0,092  0,044  mTOR complex 2 inhibitor
0,167  0,120  Dyrk kinase inhibitor
0,057  0,010  Phosphodiesterase 6C inhibitor
0,106  0,059  Carbonic anhydrase XV inhibitor
0,077  0,030  SULT2A1 substrate
0,071  0,026  Estrogen agonist
0,061  0,017  Carnitine palmitoyltransferase 1B inhibitor
0,073  0,029  Collagenase 3 inhibitor
0,235  0,191  Antibacterial
0,180  0,137  Antineoplastic (colon cancer)
0,182  0,139  Superoxide dismutase inhibitor
0,197  0,153  Antineoplastic (multiple myeloma)
0,116  0,072  Alkylator
0,064  0,022  Aconitate hydratase inhibitor
0,098  0,056  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,051  0,009  Cholesterol absorption inhibitor
0,082  0,041  Histidine decarboxylase inhibitor
0,137  0,097  Pulmonary hypertension treatment
0,180  0,140  Antineoplastic (ovarian cancer)
0,201  0,161  Thyroid hormone antagonist
0,072  0,033  Beta tubulin antagonist
0,092  0,053  Antiviral (Hepatitis A)
0,141  0,103  Antianginal
0,110  0,071  Aldehyde dehydrogenase substrate
0,184  0,146  Antineoplastic (colorectal cancer)
0,107  0,070  SULT1A1 substrate
0,086  0,050  Carbonic anhydrase VI inhibitor
0,052  0,016  Plasmepsin II inhibitor
0,060  0,024  Heparanase inhibitor
0,073  0,038  Female sexual dysfunction treatment
0,059  0,023  Anesthetic inhalation
0,116  0,081  DNA repair enzyme inhibitor
0,151  0,116  P-glycoprotein inhibitor
0,133  0,099  UGT1A4 substrate
0,127  0,093  Peroxidase inhibitor
0,039  0,007  Sodium/glucose cotransporter inhibitor
0,113  0,082  Contraceptive female
0,135  0,104  Heat shock protein 90 alpha antagonist
0,073  0,043  Premenstrual syndrome treatment
0,043  0,013  Ceramide glucosyltransferase inhibitor
0,052  0,023  Sphingosine 1-phosphate receptor agonist
0,041  0,012  GABA transporter 3 inhibitor
0,070  0,040  Leukotriene antagonist
0,106  0,077  Anesthetic local
0,036  0,007  Nicotinic acid receptor 2 antagonist
0,040  0,011  Phosphodiesterase 6B inhibitor
0,049  0,021  Sphingosine 1-phosphate receptor 1 agonist
0,072  0,044  Phenylalanine 4-hydroxylase inhibitor
0,035  0,008  Sodium/glucose cotransporter 1 inhibitor
0,045  0,018  Diamine oxidase inhibitor
0,127  0,100  Acetylcholine M1 receptor antagonist
0,119  0,093  Cachexia treatment
0,043  0,017  Squalene synthetase inhibitor
0,054  0,027  Antiviral (Herpesvirus 3, Human)
0,183  0,157  Antiviral (West Nile virus)
0,041  0,015  Sodium-dependent vitamin C transporter 2 inhibitor
0,029  0,006  Isoleucine-tRNA ligase inhibitor
0,143  0,119  Septic shock treatment
0,105  0,081  Cholesterol synthesis inhibitor
0,063  0,040  Carbamoyl phosphate synthetase inhibitor
0,120  0,096  UGT2B15 substrate
0,229  0,206  DNA directed DNA polymerase inhibitor
0,152  0,131  Antiparasitic
0,088  0,066  Antineoplastic, alkylator
0,046  0,026  HIV-1 protease inhibitor
0,142  0,122  Neurotensin receptor agonist
0,034  0,014  Thrombin receptor antagonist
0,120  0,100  Mannose-6-phosphate isomerase inhibitor
0,159  0,139  Antiviral (HIV)
0,075  0,055  Na+ K+ transporting ATPase inhibitor
0,028  0,009  Phosphodiesterase 6H inhibitor
0,028  0,009  Phosphodiesterase 6G inhibitor
0,060  0,043  Neuraminidase inhibitor
0,140  0,123  UDP-glucuronosyltransferase substrate
0,021  0,004  Integrin beta6 antagonist
0,057  0,041  Cathepsin L inhibitor
0,055  0,039  Immunoglobulin Fc receptor antagonist
0,037  0,023  Sphingosine 1-phosphate receptor 3 agonist
0,083  0,068  NADH dehydrogenase inhibitor
0,117  0,102  Antiischemic, cerebral
0,020  0,006  Thromboxane A2 agonist
0,091  0,077  Anabolic
0,025  0,011  Integrin beta5 antagonist
0,094  0,081  Monophenol monooxygenase inhibitor
0,037  0,024  Glutamate (mGluR3) antagonist
0,069  0,056  Peroxisome proliferator-activated receptor gamma antagonist
0,037  0,024  Nicotinic acid receptor agonist
0,235  0,222  Calcium channel L-type activator
0,057  0,045  Acetylcholine M3 receptor antagonist
0,025  0,013  Neutral endopeptidase inhibitor
0,130  0,118  CDC-like kinase 4 inhibitor
0,094  0,082  Choleretic
0,034  0,023  Carnitine palmitoyltransferase 1 inhibitor
0,113  0,102  Antineoplastic (carcinoma)
0,034  0,024  Carnitine palmitoyltransferase inhibitor
0,024  0,015  Phosphodiesterase 6A inhibitor
0,042  0,034  Glutamate (mGluR group III) antagonist
0,023  0,015  Monocarboxylic acid transporter 1 inhibitor
0,023  0,015  Monocarboxylic acid transporter inhibitor
0,023  0,015  Prostaglandin F2 alpha agonist
0,191  0,182  FMO3 substrate
0,087  0,079  Carbonic anhydrase III inhibitor
0,100  0,094  Antiviral (Hepatitis B)
0,060  0,054  Sphingosine 1-phosphate receptor 4 agonist
0,057  0,051  Antimycoplasmal
0,038  0,031  Dopamine D5 agonist
0,179  0,173  Prostaglandin dehydrogenase inhibitor
0,156  0,150  Immunostimulant
0,036  0,031  Cathepsin L1 inhibitor
0,097  0,092  Proteasome inhibitor
0,021  0,016  GABA transporter inhibitor
0,022  0,018  ICAM 1 antagonist
0,014  0,010  Integrin alphaVbeta6 antagonist
0,054  0,051  Antidote, heavy metal
0,018  0,014  Estrogen-related receptor gamma agonist
0,137  0,133  Antineoplastic (glioblastoma multiforme)
0,107  0,104  Antibacterial (Helicobacter pylori)
0,049  0,046  Nicotinic alpha3beta2 receptor antagonist
0,084  0,081  Creatine kinase inhibitor
0,021  0,019  Dopamine autoreceptor agonist
0,169  0,167  CYP1A2 inhibitor
0,078  0,076  3C-Like protease (SARS coronavirus) inhibitor
0,009  0,007  Integrin alphaVbeta5 antagonist
0,025  0,024  LFA antagonist
0,056  0,055  5 Hydroxytryptamine 3 agonist
0,102  0,101  Constipation treatment
0,048  0,048  Alcohol oxidase inhibitor
0,124  0,124  Interferon gamma antagonist
0,043  0,042  Metalloproteinase-3 inhibitor
0,015  0,015  G-protein-coupled receptor 120 agonist
0,075  0,075  Myeloperoxidase inhibitor
0,063  0,063  Calcium channel L-type blocker

